Cargando…

Larotrectinib for solid tumours

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218391/
https://www.ncbi.nlm.nih.gov/pubmed/35755993
http://dx.doi.org/10.18773/austprescr.2022.035
_version_ 1784731877512314880
collection PubMed
description
format Online
Article
Text
id pubmed-9218391
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-92183912022-06-23 Larotrectinib for solid tumours Aust Prescr New Drugs NPS MedicineWise 2022-06-01 2022-06 /pmc/articles/PMC9218391/ /pubmed/35755993 http://dx.doi.org/10.18773/austprescr.2022.035 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Larotrectinib for solid tumours
title Larotrectinib for solid tumours
title_full Larotrectinib for solid tumours
title_fullStr Larotrectinib for solid tumours
title_full_unstemmed Larotrectinib for solid tumours
title_short Larotrectinib for solid tumours
title_sort larotrectinib for solid tumours
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218391/
https://www.ncbi.nlm.nih.gov/pubmed/35755993
http://dx.doi.org/10.18773/austprescr.2022.035